Phage therapy is a precision tool in the fight against antimicrobial resistance (AMR). Access, however, remains constrained by clinical and commercial integration, fragmented infrastructure, ...

Just weeks after discharge, the patient is back at the hospital. This time, the infection has worsened, sepsis has set in, and emergency surgery is needed. A preventable outcome had intervention come ...

Guidelines recommend against use of midline catheters for vancomycin-based outpatient parenteral antimicrobial therapy (OPAT), but evidence supporting the guidance is limited. This retrospective study ...

Antimicrobial resistance (AMR) threatens the effectiveness of standard anti-infective drugs and calls for therapeutic concepts that can bypass, disable, or ...

As antibiotic resistance reaches critical levels worldwide, the 8th World Congress on Targeting Phage Therapy (June 10–11, 2025) returns to Berlin, bringing together over 75 international speakers and ...

A recent Clinical Infectious Diseases study evaluated the effectiveness of Cefoxitin in the treatment of Endometritis and Intraamniotic Infections (IAI). This follows the update of local order sets ...

Early receipt of a phenotype-desirable antimicrobial therapy (PDAT), defined as beta-lactam antibiotic with the narrowest spectrum of activity that effectively targets the pathogen’s phenotype, ...

Once seen as a lasting medical breakthrough, antibiotics are steadily losing their effectiveness. Around the world, ...

Antimicrobial resistance (AMR) arises when microorganisms, particularly bacteria, evolve mechanisms against antimicrobial agents to survive. These mechanisms may arise through either spontaneous ...

Patients who are prescribed antibiotics during immune checkpoint blockade therapy for solid tumors face a heightened risk for ...

The ninth known case of welder’s anthrax, and the first clinical use of the monoclonal antibody medication obiltoxaximab to ...